(ASLN) Aslan Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Aslan Pharmaceuticals | (ASLN) share price targets
Complete technical analysis of Aslan Pharmaceuticals (ASLN) by charts plus indicators, forecast predictions and share price targets for Aslan Pharmaceuticals (ASLN)
Aslan Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Aslan Pharmaceuticals is 478384
Date | Daily Closing Price | Open | High | Low | Volume |
18 Thu Jul 2024 | 0.60 | 0.63 | 0.70 | 0.60 | 1.685 times |
17 Wed Jul 2024 | 0.70 | 0.53 | 0.81 | 0.47 | 5.843 times |
16 Tue Jul 2024 | 1.11 | 1.33 | 1.35 | 1.03 | 1.253 times |
15 Mon Jul 2024 | 1.38 | 1.31 | 1.65 | 1.31 | 2.42 times |
12 Fri Jul 2024 | 2.55 | 2.46 | 2.73 | 2.46 | 0.047 times |
11 Thu Jul 2024 | 2.47 | 2.26 | 2.50 | 2.17 | 0.043 times |
10 Wed Jul 2024 | 2.29 | 2.22 | 2.29 | 2.03 | 0.031 times |
09 Tue Jul 2024 | 2.20 | 2.06 | 2.26 | 2.06 | 0.027 times |
08 Mon Jul 2024 | 2.08 | 2.01 | 2.21 | 1.92 | 0.087 times |
05 Fri Jul 2024 | 1.93 | 2.23 | 2.37 | 1.82 | 0.13 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.3 as stoploss in an intra day buy trade for a target of 1.22. However, stock will show a bearish move below 0.3.
Share price targets for Aslan Pharmaceuticals (ASLN)
Target Type | Value |
Downside Target | 0.27 |
Downside Target | 0.28 |
Downside Target | 0.34 |
Downside Target | 0.39 |
Downside Target | 0.41 |
Downside Target | 0.47 |
Downside Target | 0.50 |
Downside Target | 0.54 |
Upside Target | 0.62 |
Upside Target | 1.65 |
Upside Target | 1.82 |
Upside Target | 1.92 |
Upside Target | 2.09 |
Upside Target | 2.53 |
Upside Target | 2.73 |
Intraday share price targets for Aslan Pharmaceuticals (ASLN)
Target Type | Value |
Downside Intraday Target | 0.16 |
Downside Intraday Target | -0.27 |
Upside Intraday Target | 1.34 |
Upside Intraday Target | 2.09 |
Upside Intraday Target | 0.91 |
Weekly technical analysis of Aslan Pharmaceuticals (ASLN)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Thu Jul 2024 | 0.60 | 1.31 | 1.65 | 0.47 | 47.72 times |
12 Fri Jul 2024 | 2.55 | 2.01 | 2.73 | 1.92 | 0.944 times |
05 Fri Jul 2024 | 1.93 | 2.20 | 2.53 | 1.82 | 0.333 times |
03 Wed Jul 2024 | 2.38 | 0.31 | 2.53 | 0.28 | 0.461 times |
28 Fri Jun 2024 | 0.30 | 0.34 | 0.34 | 0.27 | 1.12 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Aslan Pharmaceuticals (ASLN)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Thu Jul 2024 | 0.60 | 0.31 | 2.73 | 0.28 | 1.561 times |
28 Fri Jun 2024 | 0.30 | 0.45 | 0.50 | 0.27 | 0.832 times |
31 Fri May 2024 | 0.43 | 0.47 | 0.54 | 0.39 | 0.245 times |
30 Tue Apr 2024 | 0.46 | 0.61 | 0.62 | 0.41 | 0.348 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Aslan Pharmaceuticals (ASLN)
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aslan Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Aslan Pharmaceuticals in short term but the sell signal is initial and weak.
Aslan Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aslan Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aslan Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.92 and Aslan Pharmaceuticals (ASLN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aslan Pharmaceuticals (ASLN) stock. Volume based technical analysis of Aslan Pharmaceuticals (ASLN) stock is negative.
Aslan Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aslan Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Aslan Pharmaceuticals in short term but the sell signal is initial and weak.
Aslan Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aslan Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aslan Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.92 and Aslan Pharmaceuticals (ASLN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aslan Pharmaceuticals (ASLN) stock. Volume based technical analysis of Aslan Pharmaceuticals (ASLN) stock is negative.
Aslan Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.